Vital Farms (NASDAQ:VITL) Sets New 52-Week Low - What's Next?

Key Points

• Vital Farms (VITL) hit a new 52‑week low of $17.91 (last $18.27) on heavy volume, trading well below its 50‑day ($27.36) and 200‑day ($34.97) moving averages with a market cap around $822M.
• Analyst views are mixed: the consensus is a Moderate Buy with a $45 price target, but recent notes include downgrades from Benchmark (to "hold") and Zacks (to "strong sell").
• Vital Farms reported Q4 EPS of $0.35, missing estimates by $0.03 while revenue rose 28.6% YoY to $213.6M, and insiders have sold roughly 86,734 shares in the last three months while holding about 21.3% of the stock.

Vital Farms, Inc. (NASDAQ:VITL - Get Free Report)'s share price hit a new 52-week low during trading on Monday . The stock traded as low as $17.91 and last traded at $18.27, with a volume of 724600 shares trading hands. The stock had previously closed at $19.89.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on VITL shares. Benchmark lowered Vital Farms from a "buy" rating to a "hold" rating in a research note on Thursday, February 26th. Zacks Research lowered shares of Vital Farms from a "hold" rating to a "strong sell" rating in a research note on Monday, March 2nd. Jefferies Financial Group reiterated a "buy" rating and set a $52.00 target price on shares of Vital Farms in a research report on Wednesday, December 17th. DA Davidson set a $47.00 price objective on Vital Farms and gave the company a "buy" rating in a report on Wednesday, December 17th. Finally, Needham & Company LLC cut their target price on Vital Farms from $45.00 to $35.00 and set a "buy" rating on the stock in a research report on Monday, March 2nd. Nine analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Vital Farms has a consensus rating of "Moderate Buy" and a consensus price target of $45.00.

Vital Farms Stock Performance

The company has a 50-day moving average price of $27.36 and a two-hundred day moving average price of $34.97. The stock has a market capitalization of $822.47 million, a P/E ratio of 12.75 and a beta of 1.14. The company has a quick ratio of 1.61, a current ratio of 2.16 and a debt-to-equity ratio of 0.01.

Vital Farms (NASDAQ:VITL - Get Free Report) last released its quarterly earnings results on Thursday, February 26th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.03). Vital Farms had a net margin of 8.73% and a return on equity of 20.69%. The business had revenue of $213.55 million during the quarter, compared to analysts' expectations of $212.83 million. During the same period in the previous year, the business earned $0.23 EPS. The business's revenue was up 28.6% on a year-over-year basis. Equities analysts expect that Vital Farms, Inc. will post 1.11 earnings per share for the current year.

Insider Activity at Vital Farms

In other Vital Farms news, CEO Russell Diez-Canseco sold 16,734 shares of the company's stock in a transaction on Monday, December 15th. The shares were sold at an average price of $35.05, for a total value of $586,526.70. Following the completion of the transaction, the chief executive officer directly owned 649,684 shares in the company, valued at approximately $22,771,424.20. This represents a 2.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Matthew Ohayer sold 25,000 shares of the business's stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $30.85, for a total transaction of $771,250.00. Following the sale, the insider owned 6,361,190 shares in the company, valued at approximately $196,242,711.50. This trade represents a 0.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 86,734 shares of company stock worth $2,498,827 over the last three months. Insiders own 21.30% of the company's stock.

Institutional Trading of Vital Farms

Institutional investors have recently added to or reduced their stakes in the business. Triumph Capital Management purchased a new stake in shares of Vital Farms during the fourth quarter valued at $25,000. Quarry LP bought a new position in shares of Vital Farms during the 4th quarter valued at $27,000. Exchange Traded Concepts LLC bought a new position in shares of Vital Farms during the 3rd quarter valued at $28,000. Global Retirement Partners LLC boosted its stake in shares of Vital Farms by 4,382.6% in the 4th quarter. Global Retirement Partners LLC now owns 1,031 shares of the company's stock worth $33,000 after buying an additional 1,008 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Vital Farms by 225.6% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,452 shares of the company's stock worth $46,000 after buying an additional 1,006 shares during the last quarter. 98.59% of the stock is currently owned by hedge funds and other institutional investors.

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms' supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.